Zimmer Biomet Holdings Inc
Geschlossen
BrancheGesundheitswesen
89.97 2.76
Übersicht
Veränderung der Aktienkurses
24h
Min
87.54
Max
90.5
Einkommen | 99M 239M |
|---|---|
Verkäufe | -157M 2.1B |
KGV Branchendurchschnitt | 22.797 50.958 |
EPS | 2.09 |
Dividendenrendite | 1.1 |
Gewinnspanne | 11.43 |
Angestellte | 17,000 |
EBITDA | 84M 538M |
Empfehlungen | Neutral |
|---|---|
12-Monats-Prognose | +7.02% upside |
Dividendenrendite Branchendurchschnitt | 1.10% 2.41% |
|---|---|
Nächstes Ergebnis | 6. Aug. 2026 |
Nächste Dividendenausschüttung | 31. Juli 2026 |
Nächstes Ex-Dividendendatum | 25. Juni 2026 |
Marktkapitalisierung | -899M 17B |
|---|---|
Vorheriger Eröffnungskurs | 87.21 |
Vorheriger Schlusskurs | 89.97 |
Nachrichtenstimmung
By Acuity
50%
50%
146 / 342 Ranking in Healthcare
Zimmer Biomet Holdings Inc Chart
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
Über Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.